338 related articles for article (PubMed ID: 15831463)
1. Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation.
Ma K; Chan JK; Zhu G; Wu Z
Mol Cell Biol; 2005 May; 25(9):3575-82. PubMed ID: 15831463
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2.
Grégoire S; Xiao L; Nie J; Zhang X; Xu M; Li J; Wong J; Seto E; Yang XJ
Mol Cell Biol; 2007 Feb; 27(4):1280-95. PubMed ID: 17158926
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional activation of the myogenin gene by MEF2-mediated recruitment of myf5 is inhibited by adenovirus E1A protein.
Johanson M; Meents H; Ragge K; Buchberger A; Arnold HH; Sandmöller A
Biochem Biophys Res Commun; 1999 Nov; 265(1):222-32. PubMed ID: 10548518
[TBL] [Abstract][Full Text] [Related]
4. Mef2c is activated directly by Ets transcription factors through an evolutionarily conserved endothelial cell-specific enhancer.
De Val S; Anderson JP; Heidt AB; Khiem D; Xu SM; Black BL
Dev Biol; 2004 Nov; 275(2):424-34. PubMed ID: 15501228
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C.
Sartorelli V; Huang J; Hamamori Y; Kedes L
Mol Cell Biol; 1997 Feb; 17(2):1010-26. PubMed ID: 9001254
[TBL] [Abstract][Full Text] [Related]
6. c-Myb acetylation at the carboxyl-terminal conserved domain by transcriptional co-activator p300.
Tomita A; Towatari M; Tsuzuki S; Hayakawa F; Kosugi H; Tamai K; Miyazaki T; Kinoshita T; Saito H
Oncogene; 2000 Jan; 19(3):444-51. PubMed ID: 10656693
[TBL] [Abstract][Full Text] [Related]
7. Regulation of HDAC9 gene expression by MEF2 establishes a negative-feedback loop in the transcriptional circuitry of muscle differentiation.
Haberland M; Arnold MA; McAnally J; Phan D; Kim Y; Olson EN
Mol Cell Biol; 2007 Jan; 27(2):518-25. PubMed ID: 17101791
[TBL] [Abstract][Full Text] [Related]
8. The homeobox gene Arx is a novel positive regulator of embryonic myogenesis.
Biressi S; Messina G; Collombat P; Tagliafico E; Monteverde S; Benedetti L; Cusella De Angelis MG; Mansouri A; Ferrari S; Tajbakhsh S; Broccoli V; Cossu G
Cell Death Differ; 2008 Jan; 15(1):94-104. PubMed ID: 17932502
[TBL] [Abstract][Full Text] [Related]
9. Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors.
Grégoire S; Yang XJ
Mol Cell Biol; 2005 Mar; 25(6):2273-87. PubMed ID: 15743823
[TBL] [Abstract][Full Text] [Related]
10. Histone chaperones cooperate to mediate Mef2-targeted transcriptional regulation during skeletal myogenesis.
Yang JH; Choi JH; Jang H; Park JY; Han JW; Youn HD; Cho EJ
Biochem Biophys Res Commun; 2011 Apr; 407(3):541-7. PubMed ID: 21414300
[TBL] [Abstract][Full Text] [Related]
11. Transcription of Myocyte enhancer factor-2 in adult Drosophila myoblasts is induced by the steroid hormone ecdysone.
Lovato TL; Benjamin AR; Cripps RM
Dev Biol; 2005 Dec; 288(2):612-21. PubMed ID: 16325168
[TBL] [Abstract][Full Text] [Related]
12. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R
Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977
[TBL] [Abstract][Full Text] [Related]
13. c-Ski activates MyoD in the nucleus of myoblastic cells through suppression of histone deacetylases.
Kobayashi N; Goto K; Horiguchi K; Nagata M; Kawata M; Miyazawa K; Saitoh M; Miyazono K
Genes Cells; 2007 Mar; 12(3):375-85. PubMed ID: 17352741
[TBL] [Abstract][Full Text] [Related]
14. TRIM72, a novel negative feedback regulator of myogenesis, is transcriptionally activated by the synergism of MyoD (or myogenin) and MEF2.
Jung SY; Ko YG
Biochem Biophys Res Commun; 2010 May; 396(2):238-45. PubMed ID: 20399744
[TBL] [Abstract][Full Text] [Related]
15. Tat acetylation: a regulatory switch between early and late phases in HIV transcription elongation.
Ott M; Dorr A; Hetzer-Egger C; Kaehlcke K; Schnolzer M; Henklein P; Cole P; Zhou MM; Verdin E
Novartis Found Symp; 2004; 259():182-93; discussion 193-6, 223-5. PubMed ID: 15171254
[TBL] [Abstract][Full Text] [Related]
16. v-Src inhibits myogenic differentiation by interfering with the regulatory network of muscle-specific transcriptional activators at multiple levels.
Falcone G; Ciuffini L; Gauzzi MC; Provenzano C; Strano S; Gallo R; Castellani L; Alemà S
Oncogene; 2003 Nov; 22(51):8302-15. PubMed ID: 14614454
[TBL] [Abstract][Full Text] [Related]
17. MEF2C DNA-binding activity is inhibited through its interaction with the regulatory protein Ki-1/57.
Kobarg CB; Kobarg J; Crosara-Alberto DP; Theizen TH; Franchini KG
FEBS Lett; 2005 May; 579(12):2615-22. PubMed ID: 15862299
[TBL] [Abstract][Full Text] [Related]
18. CtBP represses p300-mediated transcriptional activation by direct association with its bromodomain.
Kim JH; Cho EJ; Kim ST; Youn HD
Nat Struct Mol Biol; 2005 May; 12(5):423-8. PubMed ID: 15834423
[TBL] [Abstract][Full Text] [Related]
19. Dual roles for MEF2A and MEF2D during human macrophage terminal differentiation and c-Jun expression.
Aude-Garcia C; Collin-Faure V; Bausinger H; Hanau D; Rabilloud T; Lemercier C
Biochem J; 2010 Sep; 430(2):237-44. PubMed ID: 20590529
[TBL] [Abstract][Full Text] [Related]
20. Differentiation-dependent lysine 4 acetylation enhances MEF2C binding to DNA in skeletal muscle cells.
Angelelli C; Magli A; Ferrari D; Ganassi M; Matafora V; Parise F; Razzini G; Bachi A; Ferrari S; Molinari S
Nucleic Acids Res; 2008 Feb; 36(3):915-28. PubMed ID: 18086704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
